Figure 2
767 × 172px
· 30,8 KB
Source Paper
Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.Cite This Figure
 > Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." *Pharmaceutics*, 2024. PMID: [39339161](https://pubmed.ncbi.nlm.nih.gov/39339161/)
<figure> <img src="https://pdfs.citedhealth.com/figures/39339161/127.png" alt="Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6)." /> <figcaption>Figure 2. Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).<br> Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." <em>Pharmaceutics</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39339161/">39339161</a></figcaption> </figure>